Preconditioning of Cardiosphere-Derived Cells With Hypoxia or Prolyl-4-Hydroxylase Inhibitors Increases Stemness and...

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Cardiovascular Research

Background:

• Cardiosphere-derived cells (CDCs) are a promising cell source for regenerating infarcted myocardium.
• Current CDC expansion protocols are lengthy, requiring over a month in vitro.
• Optimizing CDC expansion is crucial for efficient therapeutic application.

Purpose of the Study:

• To investigate the effects of hypoxic preconditioning on CDC proliferation and characteristics.
• To explore the potential of hypoxia-inducible factor prolyl-4-hydroxylase inhibitors (PHDIs) to mimic hypoxic effects.
• To assess the impact of these optimizations on CDC therapeutic potential.

Main Methods:

• CDCs were cultured under hypoxic (2% oxygen) and normoxic conditions.
• Hypoxic preconditioning effects were mimicked using PHDIs (DMOG and BIC).
• Cell proliferation, gene marker expression (stem cell, pluripotency), and metabolic activity were analyzed.

Main Results:

• Hypoxia significantly increased CDC proliferation (1.4-fold) and enhanced cardiac stem cell and pluripotency gene markers.
• Hypoxia upregulated genes involved in stem cell trafficking (SDF/CXCR-4), erythropoiesis (EPO), and angiogenesis (VEGF).
• PHDI treatment mimicked hypoxic effects, increasing proliferation and activating key pathways (HIF, EPO, CXCR-4), while decreasing oxygen consumption and increasing glycolysis.

Conclusions:

• Hypoxic preconditioning enhances CDC proliferation and expression of key therapeutic markers.
• PHDIs offer a viable alternative to hypoxia for optimizing CDC expansion.
• Optimized CDCs exhibit altered metabolism and potentially enhanced therapeutic efficacy for myocardial regeneration.